Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Open
Phase 2
This trial is looking at MK-1026 for blood cancer that has come back or following treatment that has stopped working.
Recruitment start: 27 December 2021
Recruitment end: 1 March 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Elizabeth Phillips
Merck Sharp & Dohme Ltd
Last reviewed: 29 May 2025
CRUK internal database number: 18341
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
